COPENHAGEN (Reuters) -Novo Nordisk has notified employees impacted by the drugmaker’s job cuts in the vast majority of its locations although the pace varies according to local laws, its CEO Mike Doustdar wrote in a post on LinkedIn on Friday.
Doustdar launched a restructuring drive last month, including 9,000 job cuts globally as Novo faces heated competition in the United States, the world’s biggest drug market, against rival Eli Lilly.
(Reporting by Stine Jacobsen, writing by Louise Breusch Rasmussen, editing by)
